中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
Author:(Yingdan CAO)

1.Cost-effectiveness analysis of nivolumab in the second-line treatment of metastatic clear cell renal cell carcinoma

Yingdan CAO ; Fenghao SHI ; Rui MENG ; Pingyu CHEN ; Zhengyang FEI ; Xueke ZHANG ; Aixia MA

China Pharmacy 2022;33(10):1233-1239

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO